Article
Author(s):
New York - A single IV injection of anti-IL-12 antibody, even at low doses, resulted in significant improvement in PASI scores, according to results of a study presented at the recent International Psoriasis Symposium, held here.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.